Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland
Samira Bell, Jacqueline Campbell, Emilie Lambourg, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 4, pp. 677-686
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1760-1774
Open Access | Times Cited: 80
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic
Ailish Nimmo, Dale Gardiner, Ines Ushiro‐Lumb, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1312-1329
Open Access | Times Cited: 76
Severity of COVID-19 after Vaccination among Hemodialysis Patients
Damien Ashby, Ben Caplin, Richard Corbett, et al.
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 6, pp. 843-850
Open Access | Times Cited: 48
Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada
Kyla L. Naylor, S. Joseph Kim, Graham Smith, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 9, pp. 2228-2236
Open Access | Times Cited: 39
Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study
Peter J. Gallacher, David L. Yeung, Samira Bell, et al.
European Heart Journal (2024)
Open Access | Times Cited: 5
Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies
G. Olivieri, Donato Amodio, Emma Concetta Manno, et al.
Vaccine (2025) Vol. 51, pp. 126853-126853
Open Access
Safety and tolerability of molnupiravir and nirmatrelvir/ritonavir in patients with advanced chronic kidney disease and kidney failure; a cohort study
Rani Sawtell, Tianqi Ouyang, Daiana Moreno, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
SARS‐CoV‐2 vaccine antibody response and breakthrough infections in transplant recipients
Benedict Vanlerberghe, Casper Vrij, Kris Bogaerts, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 12
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
Chiara Cantarelli, Andrea Angeletti, Laura Perin, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 10, pp. 1816-1828
Open Access | Times Cited: 21
Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients
Yael Einbinder, Jeffrey Perl, Naomi Nacasch, et al.
American Journal of Nephrology (2022) Vol. 53, Iss. 7, pp. 586-590
Open Access | Times Cited: 20
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study
Paul Martin, Sarah Gleeson, Candice Clarke, et al.
The Lancet Regional Health - Europe (2022) Vol. 21, pp. 100478-100478
Open Access | Times Cited: 19
Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant
Sam M. Murray, Maria Chiara Barbanti, Cori Campbell, et al.
British Journal of Haematology (2022) Vol. 198, Iss. 4, pp. 668-679
Open Access | Times Cited: 18
Effects of SARS-CoV-2 vaccination on the severity of COVID-19 infection in patients on chronic dialysis
Jing Miao, Elsa Olson, Sally Houlihan, et al.
Journal of Nephrology (2023) Vol. 36, Iss. 5, pp. 1321-1328
Open Access | Times Cited: 10
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial
Meghan E. Sise, Jose Ramon Santos, Jason D. Goldman, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 5, pp. 1172-1181
Open Access | Times Cited: 3
Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine
Xuehan Zhang, Qingfeng Chen, Gaosi Xu
Inflammation Research (2023) Vol. 72, Iss. 5, pp. 989-1000
Open Access | Times Cited: 9
COVID-19 and cardiovascular disease in patients with chronic kidney disease
Lucia Del Vecchio, Olga Balafa, Evangelia Dounousi, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 2, pp. 177-189
Open Access | Times Cited: 8
Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function
Rituvanthikaa Seethapathy, Qiyu Wang, Sophia Zhao, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0279765-e0279765
Open Access | Times Cited: 7
The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients
S. Reshwan K. Malahe, Yvette den Hartog, Wim J. R. Rietdijk, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 9, pp. 1411-1424
Open Access | Times Cited: 6
Characteristics of the 6th Japanese wave of COVID-19 in hemodialysis patients
Munenori Haruta, Shigeru Otsubo, Yuriko Otsubo
Renal Replacement Therapy (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure
Wonkyung Cho, Destiny Harden, Daiana Moreno, et al.
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 8, pp. 1912-1914
Open Access | Times Cited: 5
Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients
Satoshi Takai, Hayato Nishida, Hiromi Ito, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Comparison of COVID-19 Hospitalization and Death Between Solid Organ Transplant Recipients and the General Population in Canada, 2020–2022
Kyla L. Naylor, Greg Knoll, Darin Treleaven, et al.
Transplantation Direct (2024) Vol. 10, Iss. 7, pp. e1670-e1670
Open Access | Times Cited: 1
COVID-19 vaccine effectiveness in patients with non–dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada
Mohammad Atiquzzaman, Yuyan Zheng, Lee Er, et al.
Kidney International (2022) Vol. 102, Iss. 6, pp. 1420-1423
Open Access | Times Cited: 8
Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients – a case series with four patients
Johanna Schneider, Rika Wobser, W Kühn, et al.
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
What has vaccination against COVID-19 in CKD patients taught us?
Mattia Rossi, Giuseppina Pessolano, Giovanni Gambaro
Journal of Nephrology (2023) Vol. 36, Iss. 5, pp. 1257-1266
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top